Employees Retirement System of Texas’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-11,668
| Closed | -$649K | – | 543 |
|
2022
Q2 | $649K | Hold |
11,668
| – | – | 0.01% | 651 |
|
2022
Q1 | $819K | Hold |
11,668
| – | – | 0.01% | 669 |
|
2021
Q4 | $1.12M | Hold |
11,668
| – | – | 0.01% | 623 |
|
2021
Q3 | $1.01M | Hold |
11,668
| – | – | 0.01% | 659 |
|
2021
Q2 | $955K | Hold |
11,668
| – | – | 0.01% | 669 |
|
2021
Q1 | $1.11M | Sell |
11,668
-8,817
| -43% | -$839K | 0.01% | 658 |
|
2020
Q4 | $1.27M | Hold |
20,485
| – | – | 0.02% | 564 |
|
2020
Q3 | $1.22M | Hold |
20,485
| – | – | 0.02% | 608 |
|
2020
Q2 | $1.43M | Hold |
20,485
| – | – | 0.02% | 562 |
|
2020
Q1 | $929K | Hold |
20,485
| – | – | 0.02% | 596 |
|
2019
Q4 | $1.33M | Hold |
20,485
| – | – | 0.02% | 639 |
|
2019
Q3 | $1.27M | Sell |
20,485
-7,888
| -28% | -$490K | 0.02% | 652 |
|
2019
Q2 | $2.02M | Sell |
28,373
-12,824
| -31% | -$913K | 0.03% | 552 |
|
2019
Q1 | $3.23M | Buy |
41,197
+4,809
| +13% | +$377K | 0.05% | 439 |
|
2018
Q4 | $3.08M | Buy |
36,388
+3,206
| +10% | +$271K | 0.05% | 425 |
|
2018
Q3 | $5.68M | Sell |
33,182
-10,259
| -24% | -$1.76M | 0.08% | 303 |
|
2018
Q2 | $5.61M | Sell |
43,441
-9,618
| -18% | -$1.24M | 0.08% | 307 |
|
2018
Q1 | $5.47M | Hold |
53,059
| – | – | 0.07% | 328 |
|
2017
Q4 | $4.53M | Buy |
53,059
+19,236
| +57% | +$1.64M | 0.06% | 401 |
|
2017
Q3 | $2.87M | Buy |
33,823
+14,427
| +74% | +$1.23M | 0.04% | 533 |
|
2017
Q2 | $1.47M | Sell |
19,396
-4,649
| -19% | -$352K | 0.02% | 726 |
|
2017
Q1 | $1.59M | Hold |
24,045
| – | – | 0.02% | 709 |
|
2016
Q4 | $1.52M | Buy |
+24,045
| New | +$1.52M | 0.02% | 714 |
|